• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Pulmonary Diseases, An Issue of Medical Clinics of North America

Pulmonary Diseases, An Issue of Medical Clinics of North America

9780323938631
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
393.07 zł
334.11 zł Save 58.96 zł Tax included
Lowest price within 30 days before promotion: 334.11 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Medical Clinics, guest editor Daniel M. Goodenberger brings his considerable expertise to the topic of Pulmonary Diseases.
Product Details
Elsevier
94039
9780323938631
9780323938631

Data sheet

Publication date
2022
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
152 x 229
Weight (g)
450
  • Testing and Treating Mycobacterium tuberculosis Infection
    Care of the Seriously Ill Patient with SARS-CoV-2
    The Role of Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease
    Advances in Evaluation and Treatment of Severe Asthma (Part One)
    Advances in Evaluation and Treatment of Severe Asthma (Part Two)
    Cystic Fibrosis: Highly Effective Targeted Therapeutics and the Impact on Sex and Racial Disparities
    Advances in Surgical and Mechanical Management of Chronic Obstructive Pulmonary Disease
    Disparities in Disease Burden and Treatment of Patients Asthma and Chronic Obstructive Pulmonary Disease
    Lung Cancer Screening
    Hypersensitivity Pneumonitis: An Updated Diagnostic Guide for Internists
    Initiating Pharmacologic Treatment in Tobacco-Dependent Adults
    Electronic Cigarette Use, Misuse, and Harm
    Marijuana and the Lung: Evolving Understandings
    The Survival of the Surviving Sepsis Campaign
Comments (0)